Madison Heights, MI – May 20, 2025 – Mopec Group, a leader in anatomic and forensic pathology equipment and technology, has announced a strategic partnership with Lumea, the U.S. pioneer in digital pathology workflows and AI-powered imaging. This collaboration marks a major milestone in the advancement of pathology workflows—bringing high-resolution digital tools directly to the grossing station, the critical first step in the diagnostic journey.
A Shared Vision for the Future of Pathology
At the heart of this partnership is a shared mission: to simplify and modernize the pathology process in a way that enhances efficiency, diagnostic accuracy, and ultimately, patient outcomes. By integrating Lumea’s BxCamera® directly into Mopec’s Maestro® Encore grossing stations, pathology professionals now have access to AI-assisted small-specimen imaging right where it matters most.
This development complements Mopec’s existing large-specimen imaging capabilities, creating a unified platform that bridges analog processes with intelligent digital tools.
“This partnership is a strategic step in advancing the grossing station toward the future of digital pathology,” said Francis X. Dirksmeier, CEO of Mopec Group. “With integrated large-specimen imaging already in place, adding Lumea’s AI-assisted small-specimen imaging as an integrated solution is a natural next move for our Maestro Encore platform. Lumea’s proven digital pathology expertise aligns perfectly with our purpose to enrich life by building the platform to transform the treatment of disease.”
Why the Grossing Station Matters More Than Ever
The grossing station is one of the most pivotal points in pathology. It’s the starting line where samples are first handled, prepared, and processed for analysis. Historically, this step has relied heavily on analog tools and manual documentation, leading to variability and inefficiencies.
Lumea’s digital imaging technology fundamentally changes that by offering:
- High-resolution, real-time specimen capture
- AI-assisted image tagging and workflow optimization
- Improved specimen traceability and consistency
“We’re excited to partner with Mopec and infuse innovation directly into a pathologist’s daily workflow,” said James Thackeray, CEO of Lumea. “The grossing station is one of the most critical touchpoints in the pathology journey. Using digital tools at this stage transforms efficiency, consistency, and ultimately, patient care.”
Building a Smarter Lab
Together, Mopec and Lumea are laying the foundation for a fully digital and connected lab environment—where grossing stations become intelligent hubs, not just work surfaces. The integration of digital pathology tools directly into core lab equipment helps eliminate silos, reduce diagnostic delays, and raise the standard of care.
Looking ahead, the two companies plan to co-develop next-generation solutions that combine large and small format imaging systems into a single, unified platform—purpose-built for the evolving needs of digital pathology.
Driving Outcomes with Innovation
This partnership is more than a product integration—it’s a blueprint for what’s next in diagnostic medicine. By aligning engineering excellence with digital transformation, Mopec and Lumea are helping pathology professionals:
- Enhance diagnostic quality
- Reduce processing errors
- Increase workflow efficiency
- Shorten turnaround time for results
- Improve patient outcomes
About Mopec Group
Mopec Group, headquartered in Madison Heights, Michigan, is a vertically integrated, branded supplier and manufacturer of high-quality anatomic and forensic pathology equipment, technology, consumable products, and services. Founded in 1992, Mopec Group differentiates itself through its innovation, engineering excellence, and outcome-focused mindset. Mopec Group is elevating pathology with complete solutions for labs in hospitals, universities, morgues, and beyond. For more information, visit www.mopecgroup.com and www.mopec.com.
About Lumea
Lumea is powering efficient, affordable, and accessible digital pathology through simplified, workflow-driven innovation with both tissue-handling technology and a best-in-class viewer with AI-driven workflows. As the U.S. leader in primary clinical digital pathology, processing the highest volume of digital cases nationwide. With over a decade of expertise, Lumea has set the standard for efficiency, quality, and premium cancer diagnostics. With a global presence spanning five continents, Lumea supports over half of the U.S. urology market and top dermatology and gastroenterology groups, optimizing tissue integrity, boosting detection rates, and delivering measurable ROI. By placing patients at the core, Lumea is transforming pathology for a more precise and efficient future. Learn more at www.lumeadigital.com.
Media Contact:
Jeff Pemberton
Vice President of Marketing & Commercial Strategy
jpemberton@Mopec.com
o. 248.284.0871 | c. 810.300.2157
Bianca Collings
Lumea VP, Head of Marketing
Bianca.Collings@lumeadigital.com